US2015297802A1PendingUtilityA1
Poly (diol co-citrate) hydroxyapatite composite for tissue engineering and orthopaedic fixation devices
Est. expiryFeb 8, 2026(expired)· nominal 20-yr term from priority
A61L 27/425A61L 31/06A61L 31/123A61L 31/127A61L 27/18A61L 2430/02A61L 27/427A61L 27/12A61L 27/46A61L 31/121A61L 31/026A61L 31/148A61L 27/58
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is directed to a novel poly(diol citrates)-based bioceramic composite materials created using completely biodegradable and a bioceramic material polymers that may be used in implantable devices. More specifically, the specification describes methods and compositions for making and using bioceramic composites comprised of citric acid copolymers and a bioceramic material.
Claims
exact text as granted — not AI-modified1 .- 34 . (canceled)
35 . A composition comprising a composite of:
a) a polyester comprising one or more linear aliphatic diol monomers and a citric acid monomer; and b) a bioceramic, wherein said composition comprises said bioceramic in an amount of 40 wt % or greater.Join the waitlist — get patent alerts
Track US2015297802A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.